<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) NOVEMBER 13, 1997
----------------------------
FOCUS SURGERY, INC.
- -----------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 0-22136 77-0332937
- -----------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
113 TYNAN WAY, PORTOLA VALLEY, CA 94028
- -----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (415) 529-0730
--------------------------
N/A
- -----------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events
A. Press Release dated November 13, 1997
Item 7. Financial Statements and Exhibits
Exhibit No. Description
- ----------- -----------
99.21 Press Release dated November 13, 1997
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Focus Surgery, Inc.
---------------------------------------
(Registrant)
Date: November 13, 1997 By: /s/ RICHARD REDETT
------------------------------------
Name: Richard Redett
Title: President and Chief
Executive Officer
<PAGE>
EXHIBIT 99.21
- --------------
CONTACT:
Mr. Richard Redett
(650) 529-0730
CLARIFICATION REGARDING FOCUS SURGERY, INC.
MENLO PARK, CALIFORNIA, NOVEMBER 13, 1997 -- Focus Surgery, Inc. (OTC
symbol: FCUS), a company which is currently using the corporate name Menlo
Acquisition Corporation ("Menlo") announced today that a recent announcement
by Focus Surgery, Inc., a privately-held company located in Indianapolis,
Indiana ("Focus") regarding purported FDA approval of Focus' commencement of
clinical trials has no bearing upon and is unrelated to the business of Menlo.
Menlo has no operations, is not conducting clinical trials or developing or
marketing products or services and is not conducting business of any kind.
On February 9, 1996, Menlo filed for protection under Chapter 11 of the
federal bankruptcy laws in the United States Bankruptcy Court, Northern
District of California, Oakland division and sold substantially all of its
assets, including the right to use its name "Focus Surgery, Inc." to Takai
Hospital Supply Company, Ltd. Menlo is currently reviewing the claims of its
various creditors. It is unclear at this time whether there will be any
funds available for distribution to shareholders. Once this information has
been determined, the Company expects to file a Plan of Reorganization with
the bankruptcy court.
Investors are cautioned not to construe developments concerning Focus as
having any bearing upon the business, finances and results of operations of
Menlo. For more information contact Richard Redett at (650) 529-0730.
####
